Cargando…
A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7
BACKGROUND: Recent reports that TLR4 and TLR7 ligands can synergistically trigger Th1 biased immune responses suggest that an adjuvant that contains both ligands would be an excellent candidate for co-administration with vaccine antigens for which heavily Th1 biased responses are desired. Ligands of...
Autores principales: | Fox, Christopher B, Sivananthan, Sandra J, Duthie, Malcolm S, Vergara, Julie, Guderian, Jeffrey A, Moon, Elliot, Coblentz, David, Reed, Steven G, Carter, Darrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014409/ https://www.ncbi.nlm.nih.gov/pubmed/24766820 http://dx.doi.org/10.1186/1477-3155-12-17 |
Ejemplares similares
-
Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activity
por: Fung, HW Millie, et al.
Publicado: (2013) -
A structure-function approach to optimizing TLR4 ligands for human vaccines
por: Carter, Darrick, et al.
Publicado: (2016) -
Formulated Phospholipids as Non-Canonical TLR4 Agonists
por: Liang, Hong, et al.
Publicado: (2022) -
TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes
por: McKay, Paul F., et al.
Publicado: (2016) -
Synergistic TLR2/6 and TLR9 Activation Protects Mice against Lethal Influenza Pneumonia
por: Tuvim, Michael J., et al.
Publicado: (2012)